This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

 
 
  S.B. No. 1643
 
 
 
 
AN ACT
  relating to the monitoring of prescriptions for certain controlled
  substances; providing penalties.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 481.002, Health and Safety Code, is
  amended by amending Subdivisions (20) and (32) and adding
  Subdivision (54) to read as follows:
               (20)  "Hospital" means:
                     (A)  a general or special hospital as defined by
  Section 241.003 [(Texas Hospital Licensing Law)]; [or]
                     (B)  an ambulatory surgical center licensed under
  Chapter 243 [by the Texas Department of Health] and approved by the
  federal government to perform surgery paid by Medicaid on patients
  admitted for a period of not more than 24 hours; or
                     (C)  a freestanding emergency medical care
  facility licensed under Chapter 254.
               (32)  "Patient" means a human for whom or an animal for
  which a drug:
                     (A)  is administered, dispensed, delivered, or
  prescribed by a practitioner; or
                     (B)  is intended to be administered, dispensed,
  delivered, or prescribed by a practitioner.
               (54)  "Health information exchange" means an
  organization that:
                     (A)  assists in the transmission or receipt of
  health-related information among organizations transmitting or
  receiving the information according to nationally recognized
  standards and under an express written agreement;
                     (B)  as a primary business function, compiles or
  organizes health-related information that is designed to be
  securely transmitted by the organization among physicians, health
  care providers, or entities within a region, state, community, or
  hospital system; or
                     (C)  assists in the transmission or receipt of
  electronic health-related information among physicians, health
  care providers, or entities within:
                           (i)  a hospital system;
                           (ii)  a physician organization;
                           (iii)  a health care collaborative, as
  defined by Section 848.001, Insurance Code;
                           (iv)  an accountable care organization
  participating in the Pioneer Model under the initiative by the
  Innovation Center of the Centers for Medicare and Medicaid
  Services; or
                           (v)  an accountable care organization
  participating in the Medicare shared savings program under 42
  U.S.C. Section 1395jjj.
         SECTION 2.  Section 481.076, Health and Safety Code, is
  amended by amending Subsections (a) and (e) and adding Subsections
  (a-1) and (a-2) to read as follows:
         (a)  The director may not permit any person to have access to
  information submitted to the director under Section 481.074(q) or
  481.075 except:
               (1)  an investigator for the Texas Medical Board, the
  Texas State Board of Podiatric Medical Examiners, the State Board
  of Dental Examiners, the State Board of Veterinary Medical
  Examiners, the Texas Board of Nursing, or the Texas State Board of
  Pharmacy;
               (2)  an authorized officer or member of the department
  engaged in the administration, investigation, or enforcement of
  this chapter or another law governing illicit drugs in this state or
  another state; or
               (3)  if the director finds that proper need has been
  shown to the director:
                     (A)  a law enforcement or prosecutorial official
  engaged in the administration, investigation, or enforcement of
  this chapter or another law governing illicit drugs in this state or
  another state;
                     (B)  a pharmacist or a pharmacy technician, as
  defined by Section 551.003, Occupations Code, acting at the
  direction of a pharmacist or a practitioner who is a physician,
  dentist, veterinarian, podiatrist, or advanced practice nurse or is
  a physician assistant described by Section 481.002(39)(D) or a
  nurse licensed under Chapter 301, Occupations Code, acting at the
  direction of a practitioner and is inquiring about a recent
  Schedule II, III, IV, or V prescription history of a particular
  patient of the practitioner; or
                     (C)  a pharmacist or practitioner who is inquiring
  about the person's own dispensing or prescribing activity.
         (a-1)  A person authorized to receive information under
  Subsection (a)(3)(B) or (C) may access that information through a
  health information exchange, subject to proper security measures to
  ensure against disclosure to unauthorized persons.
         (a-2)  A person authorized to receive information under
  Subsection (a)(3)(B) may include that information in any form in
  the medical or pharmacy record of the patient who is the subject of
  the information. Any information included in a patient's medical
  or pharmacy record under this subsection is subject to any
  applicable state or federal confidentiality or privacy laws.
         (e)  The director shall remove from the information
  retrieval system, destroy, and make irretrievable the record of the
  identity of a patient submitted under this section to the director
  not later than the end of the 36th [12th] calendar month after the
  month in which the identity is entered into the system. However,
  the director may retain a patient identity that is necessary for use
  in a specific ongoing investigation conducted in accordance with
  this section until the 30th day after the end of the month in which
  the necessity for retention of the identity ends.
         SECTION 3.  Subsection (a), Section 481.127, Health and
  Safety Code, is amended to read as follows:
         (a)  A person commits an offense if the person knowingly
  gives, permits, or obtains unauthorized access to information
  submitted to the director under Section 481.074(q) or 481.075.
         SECTION 4.  Chapter 481, Health and Safety Code, is amended
  by adding Subchapter I to read as follows:
  SUBCHAPTER I.  INTERAGENCY PRESCRIPTION MONITORING WORK GROUP
         Sec. 481.351.  INTERAGENCY PRESCRIPTION MONITORING WORK
  GROUP. The interagency prescription monitoring work group is
  created to evaluate the effectiveness of prescription monitoring
  under this chapter and offer recommendations to improve the
  effectiveness and efficiency of recordkeeping and other functions
  related to the regulation of dispensing controlled substances by
  prescription.
         Sec. 481.352.  MEMBERS. The work group is composed of:
               (1)  the director or the director's designee;
               (2)  the commissioner of state health services or the
  commissioner's designee;
               (3)  the executive director of the Texas State Board of
  Pharmacy or the executive director's designee;
               (4)  the executive director of the Texas Medical Board
  or the executive director's designee;
               (5)  the executive director of the Texas Board of
  Nursing or the executive director's designee; and
               (6)  the executive director of the Texas Physician
  Assistant Board or the executive director's designee.
         Sec. 481.353.  MEETINGS. (a)  The work group shall meet at
  least quarterly.
         (b)  The work group is subject to Chapter 551, Government
  Code.
         (c)  The work group shall proactively engage stakeholders
  and solicit and take into account input from the public.
         Sec. 481.354.  REPORT.  Not later than December 1 of each
  even-numbered year, the work group shall submit to the legislature
  its recommendations relating to prescription monitoring.
         SECTION 5.  Section 168.102, Occupations Code, is amended by
  adding Subsection (d) to read as follows:
         (d)  If an applicant for a certificate under this chapter is
  under investigation by the board for a violation of this subtitle,
  board rules, or other law relating to the prescription,
  dispensation, administration, supply, or sale of a controlled
  substance, the board may not make a decision on the application
  until the board has reached a final decision on the matter under
  investigation.
         SECTION 6.  Subsection (a), Section 168.202, Occupations
  Code, is amended to read as follows:
         (a)  A violation of this chapter or a rule adopted under this
  chapter is grounds for disciplinary action, including a temporary
  suspension or restriction under Section 164.059, against a pain
  management clinic certified under this chapter or an owner or
  operator of a clinic certified under this chapter.
         SECTION 7.  This Act takes effect September 1, 2013.
 
 
 
 
 
  ______________________________ ______________________________
     President of the Senate Speaker of the House     
 
         I hereby certify that S.B. No. 1643 passed the Senate on
  April 25, 2013, by the following vote: Yeas 28, Nays 0; and that
  the Senate concurred in House amendments on May 25, 2013, by the
  following vote: Yeas 30, Nays 0.
 
 
  ______________________________
  Secretary of the Senate    
 
         I hereby certify that S.B. No. 1643 passed the House, with
  amendments, on May 22, 2013, by the following vote: Yeas 144,
  Nays 2, one present not voting.
 
 
  ______________________________
  Chief Clerk of the House   
 
 
 
  Approved:
 
  ______________________________ 
              Date
 
 
  ______________________________ 
            Governor